0
Zai Lab Limited Banner Image

Zai Lab Limited

  • Ticker ZLAB
    Exchange NASDAQ More
  • Industry Biotechnology More
  • Sector Healthcare More
Zai Lab Limited Logo Image
  • 501-1000 Employees
  • Based in Pudong, China
Zai Lab (NASDAQ:ZLAB) is an innovative commercial-stage biopharmaceutical company focused on bringing transformative medicines for cancer, infectious and autoimmune diseases to patients in China and around the world. To quickly target the large, fast-growing segments of China’s pharmaceutical market and address unmet medical needs, Zai Lab’s experienced team has secured partnerships withMore leading global biopharma companies, generating a broad pipeline of innovative drug candidates. Zai Lab has also built an in-house team with strong drug discovery and translational research capabilities, aiming to establish a global pipeline of proprietary drug candidates against targets in their focus areas. Zai Lab’s vision is to become a fully integrated biopharmaceutical company, discovering, developing, manufacturing and commercializing its portfolio in order to impact human health worldwide.
Zai Lab Limited

Most Recent Responsibility Report

Zai Lab Limited
MOST RECENT 2022 ESG Report

Zai Lab Limited does not currently have any hardcopy reports on ResponsibilityReports.com. Click the button below to request a report when hardcopies become available.

Request Information

Archived Responsibility Reports

Our service enables potential investors to review the most recent and archived Zai Lab Limited Sustainability Report, Zai Lab Limited Corporate Social Responsibility Report, Zai Lab Limited CSR Report, Zai Lab Limited Corporate Responsibility, Zai Lab Limited CR Report, Zai Lab Limited Citizenship Report, Zai Lab Limited ESG Report, and Zai Lab Limited Environmental Report online.
Zai Lab Limited Logo Image

Rate This Report

Your vote helps our reports be more useful
Rating Saved!

Thank you for your feedback!